Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MTNB

Matinas Biopharma Holdings Inc

May 01 • 04:00PM ET

0.6990

+0.0486 7.47 %

Healthcare • Biotechnology • USA • Nano • AMEX

Peers: AMRN VNDA OCUL AGEN XERS CLRB ACHV ATNM LTBR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.05	Insider Own	18.82%	Shs Outstand	6.41M	Perf Week	14.59%
Market Cap	4.48M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	5.20M	Perf Month	27.09%
Enterprise Value	1.78M	PEG	-	EPS next Q	-	Inst Own	7.05%	Short Float	0.07%	Perf Quarter	16.93%
Income	-10.96M	P/S	-	EPS this Y	-	Inst Trans	4.53%	Short Ratio	0.13	Perf Half Y	-47.84%
Sales	0.00M	P/B	0.93	EPS next Y	-	ROA	-110.46%	Short Interest	0.00M	Perf YTD	19.28%
Book/sh	0.75	P/C	1.11	EPS next 5Y	-	ROE	-176.54%	52W High	3.09 -77.38%	Perf Year	12.74%
Cash/sh	0.63	P/FCF	-	EPS past 3/5Y	25.49% 19.44%	ROIC	-199.76%	52W Low	0.48 45.63%	Perf 3Y	-97.67%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.58% 8.78%	Perf 5Y	-98.41%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	58.93%	Oper. Margin	-	ATR (14)	0.05	Perf 10Y	-97.70%
Dividend Ex-Date	-	Quick Ratio	2.79	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	69.96	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.79	EPS Q/Q	81.99%	SMA20	25.00%	Beta	1.62	Target Price	30.00
Payout	-	Debt/Eq	0.28	Sales Q/Q	-	SMA50	19.75%	Rel Volume	1.23	Prev Close	0.65
Employees	4	LT Debt/Eq	0.14	Earnings	-	SMA200	-32.53%	Avg Volume	27.11K	Price	0.70
IPO	Jul 21, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	19.43% -	Trades		Volume	33,364	Change	7.47%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)